The Latest Headlines at American Banking and Market News
Tractor Supply’s (TSCO) Neutral Rating Reaffirmed at Wedbush
Wedbush restated their neutral rating on shares of Tractor Supply (NASDAQ:TSCO – Free Report) in a research report report published on Tuesday, Benzinga reports. Wedbush currently has a $235.00 price target on the specialty... More of this article »
Tesla (NASDAQ:TSLA) Receives Sell Rating from Guggenheim
Guggenheim restated their sell rating on shares of Tesla (NASDAQ:TSLA – Free Report) in a research note released on Tuesday, Benzinga reports. They currently have a $122.00 price target on the electric vehicle producer’s... More of this article »
Take-Two Interactive Software (NASDAQ:TTWO) Receives “Outperform” Rating from Oppenheimer
Oppenheimer reiterated their outperform rating on shares of Take-Two Interactive Software (NASDAQ:TTWO – Free Report) in a research report released on Tuesday morning, Benzinga reports. Oppenheimer currently has a $185.00 price... More of this article »
TrustCo Bank Corp NY (NASDAQ:TRST) Upgraded by StockNews.com to “Hold”
StockNews.com upgraded shares of TrustCo Bank Corp NY (NASDAQ:TRST – Free Report) from a sell rating to a hold rating in a research report sent to investors on Tuesday. TrustCo Bank Corp NY Price Performance Shares of TrustCo... More of this article »
Vertex (NASDAQ:VERX) Given “Market Outperform” Rating at JMP Securities
JMP Securities reaffirmed their market outperform rating on shares of Vertex (NASDAQ:VERX – Free Report) in a research report released on Tuesday morning, Benzinga reports. They currently have a $42.00 price objective on the... More of this article »
Vertex (NASDAQ:VERX) Given New $34.00 Price Target at Bank of America
Vertex (NASDAQ:VERX – Free Report) had its price objective lowered by Bank of America from $40.00 to $34.00 in a report released on Tuesday, Benzinga reports. The firm currently has a neutral rating on the stock. Other equities... More of this article »
WaFd’s (WAFD) “Equal Weight” Rating Reaffirmed at Stephens
Stephens reaffirmed their equal weight rating on shares of WaFd (NASDAQ:WAFD – Free Report) in a research note issued to investors on Tuesday, Benzinga reports. Stephens currently has a $32.00 price objective on the bank’s... More of this article »
Vertex (NASDAQ:VERX) Price Target Cut to $32.00 by Analysts at Citigroup
Vertex (NASDAQ:VERX – Free Report) had its price target lowered by Citigroup from $34.00 to $32.00 in a research note released on Tuesday, Benzinga reports. The firm currently has a neutral rating on the stock. Several other... More of this article »
Warner Bros. Discovery (NASDAQ:WBD) Downgraded to Underperform at Wolfe Research
Wolfe Research lowered shares of Warner Bros. Discovery (NASDAQ:WBD – Free Report) from a peer perform rating to an underperform rating in a research report report published on Tuesday, MarketBeat reports. Wolfe Research currently... More of this article »
Wingstop’s (WING) Hold Rating Reaffirmed at Benchmark
Benchmark reiterated their hold rating on shares of Wingstop (NASDAQ:WING – Free Report) in a report published on Tuesday morning, Benzinga reports. Other equities research analysts also recently issued research reports about... More of this article »
Xometry (NASDAQ:XMTR) Given “Market Outperform” Rating at JMP Securities
JMP Securities reissued their market outperform rating on shares of Xometry (NASDAQ:XMTR – Free Report) in a research report report published on Tuesday, Benzinga reports. They currently have a $30.00 price target on the stock. A... More of this article »
Zions Bancorporation, National Association (NASDAQ:ZION) Given New $47.00 Price Target at Royal Bank of Canada
Zions Bancorporation, National Association (NASDAQ:ZION – Free Report) had its target price lifted by Royal Bank of Canada from $46.00 to $47.00 in a report issued on Tuesday morning, Benzinga reports. The firm currently has... More of this article »
AstraZeneca (LON:AZN) Given Hold Rating at Deutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft restated their hold rating on shares of AstraZeneca (LON:AZN – Free Report) in a research note issued to investors on Tuesday morning, Marketbeat.com reports. They currently have a £105 ($129.69)... More of this article »